Augmentation of LTP induced by primed-bursts tetanic stimulation in hippocampal CA1 area of morphine dependent rats

Brain Research

Volumn 769, Issue 1, 1997, Pages 119-124

  Mansouri, F A ^a   Motamedi, F ^a   Fathollahi, Y ^b   Atapour, N ^a   Semnanian, S ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c Institute of Biochemistry and Biophysics   (Iran)

Author keywords

Chronic morphine; Hippocampus; Long term potentiation

Indexed keywords

MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MORPHINE ADDICTION; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; ELECTRIC STIMULATION; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MORPHINE DEPENDENCE; RATS; RATS, INBRED STRAINS; REFERENCE VALUES;

EID: 0030701542     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00608-2     Document Type: Article

References (28)

1. Abraham W.G., Bear M.F. Metaplasticity: The plasticity of synaptic plasticity. Trends Neurosci. 19:1996;126-130.
2. Ackerman J.M., Womble M.D., Moises H.C. Multiple effects of long-term morphine treatment on postsynaptic B-adrenergic receptor function in hippocampus: an intracellular analysis. Brain Res. 656:1994;309-318.
3. Badavy A.A., Evans C.M. Production of tolerance and physical dependence in the rat by simple administration of morphine in drinking water. Br. J. Pharmacol. 75:1982;485-491.
4. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
5. Bramham C.R., Errington M.L., Bliss T.V.P. Naloxone blocks the induction of long-term potentiation in the lateral but not in the medial perforant pathway in the anesthetized rat. Brain Res. 449:1988;352-356.
6. Breindle A., Derrick B.E., Rodriguez S.B., Martinez J.L. Opioid receptor dependent long-term potentiation at the lateral perforant path-CA3 synapses in the rat hippocampus. Brain Res. Bull. 33:1994;17-24.
7. Chavkin C., Henriksen S.J., Siggins G.R., Bloom F.E. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu receptors in the CA1 region. Brain Res. 331:1985;366-370.
8. Derrick B.E., Martinez J.L. Opioid receptor activation is one factor underlying the frequency dependence of mossy fiber LTP induction. J. Neurosci. 14:1994;4359-4367.
9. Fathollahi Y., Motamedi F., Semnanian S., Zardoshti M. Repeated administration of pentylenetetrazole alters susceptibility of rat hippocampus to primed-burst stimulation: evidence from in vitro study on CA1 of hippocampal slices. Brain Res. 738:1996;138-141.
10. Gall C., Brecha N., Karter H.J., Chang K. Localization of enkephalin-like immunoreactivity to identified axonal and neuronal populations of the rat hippocampus. J. Comp. Neurol. 198:1981;335-350.
11. Grover L.M., Teyler T.J. Two components of long-term potentiation induced by different pattern of afferent activation. Nature. 347:1990;477-479.
12. Gruol D.L., Chavkin C., Valentino R.J., Siggin S. Dynorphin-A alters the excitability of pyramidal neurons of the rat hippocampus in vitro. Life Sci. 33(Sup. 1):1983;533-536.
13. Leung C.M.K., Dai S., Ogle C.W. Rapid induction of dependence to morphine in rats. Neuropharmacol. 25:1986;305-307.
14. Leung L.S., Ambrose S.A.U. Long-term potentiation as a function of test pulse intensity: A study using input/output profiles. Brain Res. Bull. 33:1994;453-460.
15. Linseman M.A., Corrigall W.A. Are endogenous opiates involved in potentiation of field potentials in hippocampus of the rat. Neurosci. Lett. 27:1981;319-324.
16. Madison D.V., Nicoll R.A. Enkephalin hyperpolarizes interneurones in the rat hippocampus. J. Physiol. 398:1988;123-130.
17. Martin M.R. Naloxone and long-term potentiation of hippocampal CA3 field potentials in vitro. Neuropeptides. 4:1983;45-50.
18. Morris R.G.M., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long term potentiation by an N-methyl-D-aspartate receptor antagonists, AP5. Nature (Lond.). 319:1986;774-776.
19. Neumaier J.F., Mailheau S., Chavkin C. Opioid receptor mediated responses in the dentate gyrus and CA1 region of the rat hippocampus. J. Pharmacol. Exp. Ther. 244:1988;564-570.
20. Nicoll R.A., Siggins G.R., Ling N., Bloom F.E., Guiliemin R. Neuronal actions of endorphine and enkephalin among brain regions. A comparative microiontophoretic study. Proc. Natl. Acad. Sci. USA. 74:1977;2584-2588.
21. Otto T., Eichenbaum H., Wiener S.I., Wible C.G. Learning-related patterns of CA1 spike trains parallel stimulation parameters optimal for inducing hippocampal long-term potentiation. Hippocampus. 1:1991;181-192.
22. Robinson J.H., Dunlap R., Deadwyler S.A. Differences in opiate-induced synaptic excitability of hippocampal slices prepared from tolerant and non-tolerant rats. Exp. Neurol. 77:1982;590-598.
23. Stringer J.L., Greenfeild L.J., Hackett J.T., Guyenet P.G. Blockade of long-term potentiation by phencyclidine and sigma opiates in the hippocampus in vivo and in vitro. Brain Res. 280:1983;127-138.
24. Vaccarino L.A., Couret J.L. Relationship between hypothalamic pituitary adrenal activity and blockade of tolerance to morphine analgesia by pain: a strain comparison. Pain. 63:1995;385-389.
25. Valentino R.J., Dingledine R. Pharmacological characterization of opioid effects in the rat hippocampal slice. J. Pharmacol. Exp. Ther. 223:1982;503-509.
26. Wimpey T.L., Opheim K.E., Chavkin C. Effects of chronic morphine administration on the Mu and Delta opioid responses in the CA1 region of the rat hippocampus. J. Pharm. Exp. Ther. 251:1989;405-411.
27. Wimpey T.L., Caudle R.M., Chavkin C. Chronic morphine exposure blocks opioid effects on both the early and late inhibitory postsynaptic potentials in hippocampal CA1 pyramidal cells. Neurosci. Lett. 110:1990;349-355.
28. Xie W., Lewis D.V. Opioid-mediated facilitation of long-term potentiation at the lateral perforant path-dentate granule cell synapse. J. Pharm. Exp. Ther. 256:1991;289-296.